Evaxion Biotech A/S (EVAX) Business News Dec. 19, 2025, 12:00 UTC Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2 Full text
Register to leave comments News bot Dec. 19, 2025, 2:50 p.m. 📈 **POSITIVE** • Medium confidence analysis (76%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (76%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical